158 related articles for article (PubMed ID: 38109713)
21. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
22. Renal Handling of
Uehara T; Kanazawa N; Suzuki C; Mizuno Y; Suzuki H; Hanaoka H; Arano Y
Bioconjug Chem; 2020 Nov; 31(11):2618-2627. PubMed ID: 33085454
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
[TBL] [Abstract][Full Text] [Related]
25. Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications.
Kim MK; Jeong HJ; Kao CH; Yao Z; Paik DS; Pie JE; Kobayashi H; Waldmann TA; Carrasquillo JA; Paik CH
Nucl Med Biol; 2002 Feb; 29(2):139-46. PubMed ID: 11823118
[TBL] [Abstract][Full Text] [Related]
26. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
27. Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.
Visser GW; Gerretsen M; Herscheid JD; Snow GB; van Dongen G
J Nucl Med; 1993 Nov; 34(11):1953-63. PubMed ID: 8229241
[TBL] [Abstract][Full Text] [Related]
28. Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injury.
Tekabe Y; Luma J; Li Q; Schmidt AM; Ramasamy R; Johnson LL
JACC Cardiovasc Imaging; 2012 Jan; 5(1):59-67. PubMed ID: 22239894
[TBL] [Abstract][Full Text] [Related]
29. Preparation, characterization, and in vivo biodistribution properties of synthetically cross-linked multivalent antitumor antibody fragments.
Schott ME; Frazier KA; Pollock DK; Verbanac KM
Bioconjug Chem; 1993; 4(2):153-65. PubMed ID: 7873647
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
31. Comparison of (99m)Tc-labeled PR81 and its F(ab')₂ fragments as radioimmunoscintigraphy agents for breast cancer imaging.
Salouti M; Babaei MH; Rajabi H; Foroutan H; Rasaee MJ; Rajabi AB; Mohammadnejad J; Shafiee M; Mazidi M; Daha FJ
Ann Nucl Med; 2011 Feb; 25(2):87-92. PubMed ID: 21061190
[TBL] [Abstract][Full Text] [Related]
32. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
33. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
Tekabe Y; Li Q; Rosario R; Sedlar M; Majewski S; Hudson BI; Einstein AJ; Schmidt AM; Johnson LL
Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545
[TBL] [Abstract][Full Text] [Related]
34.
Du Y; Chen Z; Duan X; Yan P; Zhang C; Kang L; Wang R
Ann Nucl Med; 2022 Apr; 36(4):360-372. PubMed ID: 35032308
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
36. Development and preclinical studies of
Lam K; Chan C; Reilly RM
MAbs; 2017 Jan; 9(1):154-164. PubMed ID: 27813707
[TBL] [Abstract][Full Text] [Related]
37. Imaging of HER2-Positive Tumors in NOD/SCID Mice with Pertuzumab Fab-Hexahistidine Peptide Immunoconjugates Labeled with [
Facca VJ; Al-Saden N; Ku A; Reilly RM
Mol Imaging Biol; 2021 Aug; 23(4):495-504. PubMed ID: 33479914
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
